Skip to main content

Table 2 Effect of A. australis venom on hematological parameters of EAC-bearing mice

From: Antitumor efficacy of the Egyptian Scorpion Venom Androctonus Australis: in vitro and in vivo study

Parameter treatment

Hemoglobin (g/dL)

RBC count (× 106/μL)

WBC count (× 103/μL)

Granulocytes (× 103/μL)

Lymphocytes (× 103/μL)

Monocytes (× 103/μL)

Platelet count (× 103/μL)

Normal control

9.72 ± 0.15

6.22 ± 0.07

5.08 ± 0.13

0.20 ± 0.02

4.64 ± 0.23

0.41 ± 0.04

248.44 ± 11.56

EAC control

6.18* ± 0.53

4.12* ± 0.27

6.27# ± 0.69

0.42# ± 0.08

5.24# ± 0.63

0.77 ± 0.14

254.89 ± 16.33

EAC + 1/10 LD50 (0.025 mg/kg BW)

8.26# ± 0.28

5.13# ± 0.29

3.57* ± 0.37

0.21 ± 0.03

2.61* ± 0.30

0.31 ± 0.09

536.33# ± 23.88

EAC + cisplatin (2 mg/kg BW)

5.98 ± 0.56

4.33 ± 0.25

5.65# ± 0.49

0.26 ± 0.04

4.63# ± 0.42

0.45 ± 0.03

599.00# ± 30.92

  1. Results are expressed as mean ± SE (n = 9)
  2. *Significant difference between the normal control and EAC control using unpaired t test (P < 0.05)
  3. #Significant difference between EAC control and treated groups using one-way ANOVA followed by the post hoc Duncan test (P < 0.05).